mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
7e-07 |